about
5-Lipoxygenase, leukotrienes biosynthesis and potential antileukotrienic agents.Azone analogues: classification, design, and transdermal penetration principles.Designing a dynamic dissolution method: a review of instrumental options and corresponding physiology of stomach and small intestine.Recent advances in design of potential quinoxaline anti-infectives.Synthesis and Antimicrobial Evaluation of 1-[(2-Substituted phenyl)carbamoyl]naphthalen-2-yl Carbamates.How can we bolster the antifungal drug discovery pipeline?Ring-substituted 8-hydroxyquinoline-2-carboxanilides as potential antimycobacterial agents.Salicylanilide carbamates: Promising antibacterial agents with high in vitro activity against methicillin-resistant Staphylococcus aureus (MRSA).Antibacterial and herbicidal activity of ring-substituted 3-hydroxynaphthalene-2-carboxanilides.Anti-infective and herbicidal activity of N-substituted 2-aminobenzothiazoles.Vibrational spectroscopic, 1H NMR and quantum chemical computational study of 4-hydroxy-2-oxo-1,2-dihydroquinoline-8-carboxylic acid.Investigation of substituted 6-aminohexanoates as skin penetration enhancers.Investigating the anti-proliferative activity of styrylazanaphthalenes and azanaphthalenediones.Salicylanilide acetates: synthesis and antibacterial evaluation.Investigating biological activity spectrum for novel quinoline analogues.Synthesis and antimicrobial evaluation of new 2-substituted 5,7-di-tert-butylbenzoxazoles.Synthesis, antimycobacterial, antifungal and photosynthesis-inhibiting activity of chlorinated N-phenylpyrazine-2-carboxamides.Investigating the activity of 2-substituted alkyl-6-(2,5-dioxopyrrolidin-1-yl)hexanoates as skin penetration enhancers.Investigating the activity spectrum for ring-substituted 8-hydroxyquinolines.Synthesis, physico-chemical properties and penetration activity of alkyl-6-(2,5-dioxopyrrolidin-1-yl)-2-(2-oxopyrrolidin-1-yl)hexanoates as potential transdermal penetration enhancers.Rhodanineacetic acid derivatives as potential drugs: preparation, hydrophobic properties and antifungal activity of (5-arylalkylidene-4-oxo-2-thioxo-1,3-thiazolidin-3-yl)acetic acids.Ring-substituted 4-hydroxy-1H-quinolin-2-ones: preparation and biological activity.Primaquine hybrids as promising antimycobacterial and antimalarial agents.Potential of agricultural fungicides for antifungal drug discovery.RP-HPLC determination of the lipophilicity of bispyridinium reactivators of acetylcholinesterase bearing a but-2-ene connecting linker.Investigating biological activity spectrum for novel quinoline analogues 2: hydroxyquinolinecarboxamides with photosynthesis-inhibiting activity.Antifungal properties of new series of quinoline derivatives.Substituted pyrazinecarboxamides: synthesis and biological evaluation.Design and Discovery of New Antibacterial Agents: Advances, Perspectives, Challenges.Antimycobacterial N-alkoxyphenylhydroxynaphthalenecarboxamides affecting photosystem II.Ring-substituted 8-hydroxyquinoline-2-carboxanilides as photosystem II inhibitors.In vitro permeation of micronized and nanonized alaptide from semisolid formulations.Antimicrobial evaluation of some arylsulfanylpyrazinecarboxylic acid derivatives.Vibrational spectroscopic and molecular docking study of (2E)-N-(4-chloro-2-oxo-1,2-dihydroquinolin-3-yl)-3-phenylprop-2-enamide.Spectroscopic (FT-IR, FT-Raman) investigations and quantum chemical calculations of 4-hydroxy-2-oxo-1,2-dihydroquinoline-7-carboxylic acid.Investigating Spectrum of Biological Activity of 4- and 5-Chloro-2-hydroxy-N-[2-(arylamino)-1-alkyl-2-oxoethyl]benzamidesPreparation of candesartan and atorvastatin nanoparticles by solvent evaporationPrimary investigation of the preparation of nanoparticles by precipitationUtilization of NIR spectroscopy in candesartan cilexetil stability studyRecent Advances on Isoniazide Derivatives
P50
Q36393782-3994D9AF-C8DF-43F8-8C3C-433EE94D728BQ38034122-7652CDAB-D3DD-4016-B0D4-575CFA738F37Q38089675-849F00E8-1BAE-47C7-9A05-2996F20097FFQ38259851-7E1F32F4-3430-4814-A0BA-A0637E92D0C8Q38746851-D1530947-E415-4CF2-8870-F1AF25A1E8E6Q38837289-3F2F0CD9-32F0-4F90-A0FF-146395355A62Q38852081-C90D96F5-9C23-441A-A388-F82EF3A7813DQ38863586-17C5790A-5F51-4CFB-BC6A-538FDD76F062Q39120754-62F6696E-01A8-4FC2-8630-686D6717C602Q39247158-E2906FA4-E299-459B-A431-EDCB92F29AE4Q39305457-25D1EF7A-FFFB-4343-AC08-480DA8A005B9Q39427914-F83B5261-D873-4BD2-B560-06F98F11CFFEQ39725467-CA145BA0-69BF-4179-A694-95CB6206F204Q40095099-E0F41716-1F56-4D87-B768-88E937B895C2Q40201703-0B37AA6F-CC08-47AB-9B26-C86CA3B9F73CQ40265709-9FAC2C4F-C0C1-41B9-A16C-F537499C920BQ42790376-03DE8D4E-9370-4973-9C4A-B86F9DC1FABCQ42833755-E53CFA94-AF0C-4AF1-97E3-3ECC06561B36Q43181314-98C38960-51EF-4C10-A8A1-D587C97D5F32Q43231846-9C7B68E0-D5CB-4F30-9EA0-F7A3C9849220Q43239086-9DD1541C-0807-42A7-A26F-7EA7A023B510Q46079037-61BCCD33-DC0E-4E26-B1E3-24DEA305AC3FQ46245123-43DE5C0D-C2E9-42DF-A630-858E6C97F927Q46642109-B547E02C-5EA3-432B-B5A7-17710E0FAA40Q46679982-7FE6824E-3D94-485C-86DD-8ABA81C039F7Q46700785-83008BFE-D067-4682-9D6C-BFC068964530Q46928041-7A08D89F-730D-4B49-8F96-EFABFD37FE9CQ46930090-43567465-C4B2-4D8B-8CE7-00D1575008ADQ50023934-5D09AA83-F18B-4B9D-9D5F-CDC944670A93Q51079475-D9BF22A8-716D-4D14-A2BC-5D52D7828D37Q51277957-B0C4C1D0-875C-421C-815B-020F5C3E047AQ53096345-50588A93-AF4B-4AE8-B36A-B29675C31157Q53236296-71A1B858-11E6-446C-92C3-747ACF157CA0Q54261192-5098BF81-E786-46A5-BA2E-FB8130FB8A51Q54520885-83776144-891E-4EAA-9F74-512EA849C146Q58260478-3311B2D7-CCA2-4257-84BA-1C37770347D5Q60313245-2B340DA9-CAA7-4932-B0C8-CC1B4382A564Q60313249-7F7230F3-C24E-482C-93EE-239508FA3BCFQ60313318-BD7EEEC4-6B16-4161-BA24-C407900D0C9AQ61877363-D26E5932-1F46-4853-856B-FA636EF87002
P50
name
Josef Jampilek
@en
type
label
Josef Jampilek
@en
prefLabel
Josef Jampilek
@en